 "SI Reporter")
SI Reporter
SI Reporter
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Page 1498 - Si Reporter
Market trips on disappointing IIP data
March IIP data at -3.5%
Markets slip on concerns over rising inflation
Bank shares lead the decline
Markets open on a flat note
Buying visible in the metal stocks
Pre-market: Choppy trades seen
Ashok Leyland, Thermax to be in focus
Markets end lower on dismal March IIP
ITC, Infosys top losers
Markets languish post-IIP data
Sensex sheds 157 points
Markets slump after disappointing March IIP data
FMCG, Capital Goods shares top losers
IRB Infra plunges 13%, down 37% in 7 days
A combined 11.43 million shares have changed hands till noon deals
JSW Steel tanks as SC orders probe in mining case
The stock tanked over 8% at Rs 606 on huge volumes
Divi's Lab rises on healthy Q4 nos, dividend bounty
Recommended a dividend of 650% or Rs 13 per share for the financial year 2011-12
Essar Oil dips on weak Q4 nos
Posts a net loss of Rs 515 crore in Q4FY12, against a net profit of Rs 321 crore in year quarter
Usha Martin slips on poor Q4 nos
The company posted a decline of 97.36% in net profit which came in at at Rs 3.61 crore
Bombay Dyeing slips on HC order to hand over land to BMC
Bombay High Court directed to hand over a third of its mill-land to BMC & MHADA
MTNL hits all-time low as loss widens
The company decided to offer VRS to about 20,000 employees, as part of its efforts to turn profitable.
Chettinad Cement surges 50% ahead of delisting offer
Board meet on May 15, to consider the delisting proposal
Relaxo Footwears soars on over 3-fold jump in Q4 net
The board has recommended a dividend @ 30% i.e. Rs 1.50 per share for the FY12
Jain Irrigation jumps on 58% net rise
Shares up 5% at Rs 79
AstraZeneca Pharma tanks on reporting loss in Q4
Reported a net loss of Rs 33 crore in Q4FY12 agaisnt net profit of Rs 15 crore in the previous year quarter
Lupin rises on hopes of launching anti-AIDS drug in the US
The Combivir in the US has a total market size of around $315 million annually.
Adani Power hits new low on dismal Q4 earnings
EBITDA margins declined to 10% in Q4FY12 against 61% in the corresponding quarter of previous fiscal